02340nas a2200241 4500000000100000008004100001100001100042700001800053700001400071700001100085700001400096700001700110700001200127700001200139700001300151700001200164245009600176856005600272300000800328490000600336520174200342022001402084 2015 d1 aSady H1 aAl-Mekhlafi H1 aWebster B1 aNgui R1 aAtroosh W1 aAl-Delaimy A1 aNasr NA1 aChua KH1 aLim YA L1 aSurin J00aNew insights into the genetic diversity of Schistosoma mansoni and S. haematobium in Yemen. uhttp://www.parasitesandvectors.com/content/8/1/544  a5440 v83 a

BACKGROUND: Human schistosomiasis is a neglected tropical disease of great importance that remains highly prevalent in Yemen, especially amongst rural communities. In order to investigate the genetic diversity of human Schistosoma species, a DNA barcoding study was conducted on S. mansoni and S. haematobium in Yemen.

METHODS: A cross-sectional study was conducted to collect urine and faecal samples from 400 children from five provinces in Yemen. The samples were examined for the presence of Schistosoma eggs. A partial fragment of the schistosome cox1 mitochondrial gene was analysed from each individual sample to evaluate the genetic diversity of the S. mansoni and S. haematobium infections. The data was also analysed together with previous published cox1 data for S. mansoni and S. haematobium from Africa and the Indian Ocean Islands.

RESULTS: Overall, 31.8 % of participants were found to be excreting schistosome eggs in either the urine or faeces (8.0 % S. mansoni and 22.5 % S. haematobium). Nineteen unique haplotypes of S. mansoni were detected and split into four lineages. Furthermore, nine unique haplotypes of S. haematobium were identified that could be split into two distinct groups.

CONCLUSION: This study provides novel and interesting insights into the population diversity and structure of S. mansoni and S. haematobium in Yemen. The data adds to our understanding of the evolutionary history and phylogeography of these devastating parasites whilst the genetic information could support the control and monitoring of urogenital and intestinal schistosomiasis in these endemic areas.

 a1756-3305